Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma

Neurology

Volumn 33, Issue 12, 1983, Pages 1565-1572

  Ongerboer De Visser, Bram W ^a,b   Somers, Reinier ^a,b   Nooyen, Willem H ^a,b   Van Heerde, Peter ^a,b   Hart, Augustinus A M ^a,b   Mc Vie, J Gordon ^a,b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; METHOTREXATE;

ARTICLE; BRAIN RADIATION; BREAST; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CARCINOMATOSIS; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DRUG THERAPY; HUMAN; LUMBAR PUNCTURE; MENINGEAL METASTASIS; THERAPY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; INJECTIONS, INTRAVENTRICULAR; MENINGEAL NEOPLASMS; METHOTREXATE; MIDDLE AGED;

EID: 0021048595     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.33.12.1565     Document Type: Article

References (18)

1. Olson ME, Chernik NL, Posner JB. Infiltration of leptomeninges by systemic cancer. Arch Neurol 1974;30:122-37.
2. Little JR, Dale ADJ, Okazaki H. Meningeal carcinomatosis. Arch Neurol 1974;30:138-43.
3. Yap HY, Yap BS, Tashima CK, Distefano A, Blumenschein GR. Meningeal carcinomatosis in breast cancer. Cancer 1978;42:283-6.
4. Yap HY, Yap BS, Rasmussen S, Levens ME, Hortobagyi GN, Blumenschein GR. Treatment for meningeal carcinomatosis in breast cancer. Cancer 1982;49:219-22.
5. Wasserstrom WR, Glass J, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors. Cancer 1982;49:759-72.
6. Shapiro WR, Posner JB, Ushio Y, Chernik NL, Young DF. Treatment of meningeal neoplasms. Cancer Treat Rep 1977;61:733-43.
7. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, ed. Symposium held at New York Academy of Medicine. New York Columbia University Press, 1949:191-205.
8. Persijn JP. A rapid enzymatic assay for methotrexate in serum. J Clin Chem Clin Biochem 1979;17:235.
9. Hryniuk WM, Bertino JR. Treatment of leukemia with large doses of methotrexate and fnlinic acid clinical biochemical correlates. J Clin Invest 1969;48:2140-55.
10. Mehta BM. ShaDiro WR. Hutchinson DJ. Distribution of 5-methyltetrahydrofolate following i.v. administration of citrovorum factor with intra-Ommaya methotrexate. Proc Am Assoc Cancer Res 1977;18:227.
11. Lankelma J, Lippens WJ, Drenthe-Schonk A, Fermond EFS, van der Klein E. Change in transfer rate of methotrexate from spinal fluid to plasma during intrathecal therapy in children and adults. Clin Pharmacokinet 1980;5:465-75.
12. Schornagel J, McVie JG. Methotrexate: a review. Cancer Treat Rev 1983 (in mess).
13. Shapiro WR, You DF, Mehta BP. Methotrexate distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 1975;293:161-6.
14. Bleyer WA, Poplack DG, Simon RM. “Concentration X Time” methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood 1978;51:835-42.
15. Rubinstein IJ, Herman MM, Long TF, et al. Disseminated leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 1975;35:291-305.
16. Price RA, Jamieson PA. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 1975;35:306-18.
17. Blever WA.I. Podack DG. Intraventricular versus intralumbar methotrexate for central nervous system leukemia: prolonged remission with the Ommaya reservoir. Med Pediatr Oncol 1979;6:207-13.
18. Gutin PH, Weiss HD, Wiernik PH, Walker MD. Intrathecal N, N’, N” - triethylene thiophosphoramide (thio-tepa) in the treatment of malignant meningeal disease (phase I-II study). Cancer 1976;38:1471-5.